Identification of novel estrogen receptor α antagonists

Journal of Steroid Biochemistry and Molecular Biology

Volumn 88, Issue 4-5, 2004, Pages 351-360

  Shao, Dalei ^a   Berrodin, Thomas J ^a   Manas, Eric ^a   Hauze, Diane ^a   Powers, Robert ^a,b   Bapat, Ashok ^a   Gonder, Daniel ^a   Winneker, Richard C ^a   Frail, Donald E ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Antagonist; Coactivators; Estrogen receptor; SRC

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR ALPHA;

ARTICLE; COMPETITIVE INHIBITION; CRYSTAL STRUCTURE; DRUG BINDING; DRUG IDENTIFICATION; DRUG RECEPTOR BINDING; DRUG SCREENING; NUCLEAR MAGNETIC RESONANCE; PROTEIN DEGRADATION;

ACETYLTRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG EVALUATION, PRECLINICAL; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; HISTONE ACETYLTRANSFERASES; HUMANS; HYDROXYTESTOSTERONES; LIGANDS; ONCOGENE PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, ESTROGEN; TRANS-ACTIVATORS;

MAMMALIA;

EID: 2442502910     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2004.01.007     Document Type: Article

References (23)

1. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141
2. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. A yeast two-hybrid system was used to identify a protein that interacts with and enhances the human progesterone receptor. Science. 270:1995;1354-1357
3. Hong H., Kohli K., Garabedian M.J., Stallcup M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cellular Biol. 17:1997;2735-2744
4. J Voegel J., Heine M.J., Zechel C., Chambon P., Gronemeyer H. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways H. EMBO J. 15:1996;3667-3675
5. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968
6. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90:1997;569-580
7. Li H., Gomes P.J., Chen J.D. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Nat. Acad. Sci. U.S.A. 94:1997;8479-8484
8. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684
9. Suen C.S., J Berrodin T., Mastroeni R., Cheskis B.J., Lyttle C.R., Frail D.E. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J. Biol. Chem. 273:1998;27645-27653
10. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736
11. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 95:1998;927-937
12. Clarke R., Leonessa F., Welch J.N., Skaar T.C. Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol. Rev. 53:2001;25-71
13. Miller C.P. SERMs: evolutionary chemistry, revolutionary biology. Curr. Pharmaceutical Design. 8:2002;2089-2111
14. Glaeser M., Floetotto T., Hanstein B., Beckmann M.W., Niederacher D. Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas. Hormone Metabol. Res. 33:2001;121-126
15. Tikkanen M.K., Carter D.J., Harris A.M., Le H.M., Azorsa D.O., Meltzer P.S., Murdoch F.E. Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells. Proc. Nat. Acad. Sci. U.S.A. 97:2000;12536-12540
16. List H.J., Lauritsen K.J., Reiter R., Powers C., Wellstein A., Riegel A.T. Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J. Biol. Chem. 276:2001;23763-23768
17. Joseph-McCarthy D., Thomas B.E., Belmarsh M., Moustakas D., Alvarez J.C. Pharmacophore-based molecular docking to account for ligand flexibility. Proteins. 51:2003;172-188
18. Ewing T., Makino S., Skillman A., Kuntz I.J. DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. Comput. Aided Mol. Design. 15:2001;411-420
19. Joseph-McCarthy D., Alvarez J.C. Automated generation of MCSS-derived pharmacophoric DOCK site points for searching multiconformation databases. Proteins. 51:2003;189-202
20. Peng J.W., Lepre C.A., Fejzo J., Abdul-Manan N., Moore J.M. Nuclear magnetic resonance-based approaches for lead generation in drug discovery. Meth. Enzymol. 338:2001;202-230
21. Giamarchi C., Solanas M., Chailleux C., Augereau P., Vignon F., Rochefort H., Richard-Foy H. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines. Oncogene. 18:1999;533-541
22. Egner U., Heinrich N., Ruff M., Gangloff M., Mueller-Fahrnow A., Wurtz J.M. Different ligands-different receptor conformations: modeling of the hER alpha LBD in complex with agonists and antagonists. Med. Res. Rev. 21:2001;523-539
23. Eiler S., Gangloff M., Duclaud S., Moras D., Ruff M. Overexpression, purification, and crystal structure of native ER alpha LBD. Protein Exp. Purif. 22:2001;165-173